Skip to main content

Table 2 Demographics, comorbidities and antithrombotic medication use (N = 789)

From: Intracranial haemorrhage detected by cerebral computed tomography after falls in hospital acute medical wards

Characteristic n (%)
Demographics
 Median age (interquartile range) in years 77 (66–84)
 Male sex 445 (56.4)
Comorbidities
 Diabetes 276 (35.0)
 Hypertension 414 (52.5)
 Cancer
  No intracranial involvement 123 (15.6)
  Intracranial involvement 19 (2.4)
 eGFR< 30 ml/min/1.73m2 83 (10.5)
 Liver cirrhosis 43 (5.8)
 Coagulopathy INR ≥ 1.5 31 (3.9)
 Platelet count < 50,000/μL 15 (1.9)
 Cognitive impairment
  Dementia 144 (18.3)
  Intellectual disability or ABI 27 (3.4)
 Delirium 201 (25.4)
 Obesitya 158 (25.7)
Median BMI (interquartile range) in kg/m2 25.6 (21.5–30.4)
Medications affecting coagulation
 Single antiplatelet 245 (31.1)
 Dual antiplatelet 51 (6.5)
 Anticoagulants
  Warfarin 65 (8.2)
  Novel oral anticoagulantsb 67 (8.5)
  Heparin (therapeutic dosage) 35 (4.4)
 Non-steroidal anti-inflammatories 22 (2.8)
  1. ABI Acquired brain injury, BMI Body mass index
  2. aData missing in 22.1% of patients
  3. bapixiban, rivaroxaban, or dabigatran